US Patent Innovations, LLC Opens State-Of-The-Art Scientific Research Facility To Advance Uses Of Plasma Technology And Techniques In Medicine

New Laboratory Facility Specializes in Biomedical, Proteomics, Molecular Biology, Regenerative and Translational Biology

Nov 14, 2014, 07:00 ET from US Patent Innovations, LLC

TAKOMA PARK, Md., Nov. 14, 2014 /PRNewswire/ -- US Patent Innovations, LLC (USPI) today announced the opening of its state-of-the-art research laboratory facility, through its newest affiliate, the Jerome Canady Research Institute for Advanced Biological and Technological Sciences, Benefit LLC (JCRI), an in-house clinical research hub specializing in the fields of Biomedical, Proteomics, Molecular Biology, Regenerative and Translational Biology.

JCRI composes part of USPI's new 45,000 square-foot Canady Innovation Center (CIC), which houses a cross-functional team of global scientists, physicians, clinicians, healthcare professionals and engineers who collaborate to create new innovative plasma devices. JCRI's mission is to bring forward plasma-based technologies and techniques in biomedical research and regenerative biology in the pursuit of the eradication of cancer and other systemic diseases.

"Conducting on-site research with a team of leaders in healthcare, science and technology that share my passion and commitment to the eradication of cancer is a remarkable accomplishment," said JCRI CEO, Chief Science Officer and biomedical device inventor, Jerome Canady, MD. "The research we're conducting will address important questions in plasma medicine and will enable plasma researchers to use newer therapeutics in the prevention, management and treatment of cancer and other diseases with high mortality rates."

The JCRI facility utilizes cutting-edge technology to effectively conduct research in Molecular and Translational Biology, Microscopy, Personalized Cancer Therapy, and Proteomics. The laboratory's in-house scientists and engineers collaborate with physicians and surgeons to accelerate the development of new plasma-based devices that can transfigure medicine and dramatically improve patient outcomes.

"It's an honor to work alongside Dr. Canady and to lead this astonishing team of researchers and scientists," said Dr. Arpitha Parthasarathy, PhD, Director, JCRI. "Under Dr. Canady's guidance, our team is applying its collective knowledge of translational and molecular biology towards the greater goal of bringing plasma research to the forefront of cancer management, and perhaps one day, its cure."

The Canady Innovation Center (CIC) is the first facility of its kind, housing a family of four affiliates within one facility. In addition to JCRI, these affiliates include USPI subsidiaries; Canady Biotechnology, LLC (Manufacturing), Canady Robotics, LLC (Robotic Products), and Plasma Medicine Life Sciences, LLC (Device Design & Development).

About US Patent Innovations
US Patent Innovations, LLC (USPI) is a private investor-owned US company founded by Jerome Canady, MD. USPI has over 100 members, whose main focus is to invest in new and innovative technologies in the fields of electrosurgery and plasma medicine.

Media Contacts
Aida Abramyan | Justin Cooper
Rogers & Cowan
310-854-8126 | 310-854-8120
aabramyan@rogersandcowan.com 
jcooper@rogersandcowan.com

SOURCE US Patent Innovations, LLC